Our progress toward a smoke-free future as of Q2 2024
1 As of June 30, 2024. 2 As of December 31, 2023. Important Note: This information should be read in conjunction with the Philip Morris International Inc. earnings release dated July 23, 2024, as well as the accompanying glossary of key terms, definitions, explanatory notes, select financial information and reconciliations of non-GAAP financial measures, both of which are available on our Investor Relations pages. “PMI” refers to Philip Morris International Inc. and its subsidiaries.
Watch: In the spotlight
Why invest in PMI?
We are investing behind innovation and delivering sustainable growth from our leading smoke-free products, which are a much better choice than continued smoking.
Share Price PM (Common Stock)
$11838
0.00 (0%)
Latest news & press releases
Media Center-
Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex
-
Philip Morris International Increases Dividend by 3.8% to Annualized Rate of $5.40 per Share
-
New KPMG Report Shows Illicit Cigarette Consumption Still at Worrying Levels in the European Union, With Organized Crime Moving Operations Closer to Western Countries
-
Philip Morris International Participates in 2024 Barclays Global Consumer Staples Conference
This site is operated for the purpose of providing general information about us. The site is not operated for advertising or marketing purposes. The material on this site should not be regarded as an offer to sell, or a solicitation of an offer to buy, any product of PMI. Such products are sold only in compliance with the laws of the particular jurisdictions in which they are sold.